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Abstract
ATP-dependent nucleosome remodelers of the CHD family play important roles in chromatin regulation during
development and differentiation. The ubiquitously expressed CHD3 and CHD4 proteins are essential for stem cell function
and serve to orchestrate gene expression in different developmental settings. By contrast, the closely related CHD5 is
predominantly expressed in neural tissue and its role is believed to be restricted to neural differentiation. Indeed, loss of
CHD5 contributes to neuroblastoma. In this study, we first demonstrate that CHD5 is a nucleosome-stimulated ATPase. We
then compare CHD3/4 and CHD5 expression in mouse brain and show that CHD5 expression is restricted to a subset of
cortical and hippocampal neurons whereas CHD3/4 expression is more widespread. We also uncover high levels of CHD5
expression in testis. CHD5 is transiently expressed in differentiating germ cells. Expression is first detected in nuclei of post-
meiotic round spermatids, reaches a maximum in stage VIII spermatids and then falls to undetectable levels in stage IX
spermatids. Surprisingly, CHD3/4 and CHD5 show complementary expression patterns during spermatogenesis with CHD3/
4 levels progressively decreasing as CHD5 expression increases. In spermatocytes, CHD3/4 localizes to the pseudoautosomal
region, the X centromeric region and then spreads into the XY body chromatin. In postmeiotic cells, CHD5 colocalises with
macroH2A1.2 in association with centromeres and part of the Y chromosome. The subnuclear localisations of CHD4 and
CHD5 suggest specific roles in regulation of sex chromosome chromatin and pericentromeric chromatin structure prior to
the histone-protamine switch.
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Introduction
ATP-dependent nucleosome remodelers are important regula-
tors of the epigenome. They utilise energy derived from ATP
hydrolysis to modulate histone:DNA interactions resulting in
nucleosome repositioning, nucleosome assembly and disassemby
or histone variant exchange. Nucleosome remodelers affect a
variety of fundamental biological processes including gene
transcription, DNA repair, DNA replication, chromosome cohe-
sion, stem cell maintenance and differentiation. Mutation or
misregulation of nucleosome remodelers can cause a variety of
diseases ranging from developmental disorders to cancer [1].
ATP-dependent nucleosome remodelers share a conserved
SNF2-type ATPase/helicase domain [2]. They are grouped into
distinct subfamilies based on the presence of additional domains.
The chromodomain-helicase-DNA-binding (CHD) family of
nucleosome remodelers comprises nine proteins and is charac-
terised by the presence of two chromodomains [3–5]. Three CHD
proteins (CHD3, CHD4 and CHD5) share a similar domain
structure that includes tandem PHD finger and chromo-domains
(Fig. 1A). Sequence conservation between these proteins is highest
in the catalytic domain (Fig. 1B). A higher sequence variation is
evident outside of the catalytic domain (here referred to as the N-
and C-terminal regions). In particular, CHD5 possesses a 181
amino acid stretch within the C-terminal region (aa 1556 to 1740)
that is unique to CHD5.
The PHD fingers of both CHD4 and CHD5 have been
demonstrated to bind the unmodified histone H3 tail in vitro [6,7].
Binding is abrogated by methylation of certain lysine residues such
as the di- or tri-methylation of lysine 4 (H3K4me2/3) [6–10].
The nucleosome remodeling activities of CHD3 and CHD4
have been extensively analysed in vitro. The sequence similarity
between the ATPase/helicase domains of CHD3, CHD4 and
CHD5 indicates that CHD5 might also be a nucleosome
remodeler. However, recent results suggest that sequence similar-
ity of the catalytic domain is a poor predictor of nucleosome
remodeling properties as these properties are subject to tight
regulation by intramolecular interactions [11–13]. Structural
analyses of CHD1 and CHD4 have demonstrated that the PHD
fingers, the chromodomains and a C-terminal conserved domain
of unknown function fold back onto the ATPase domain to
modulate its activity [11–13]. These findings have revealed that
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regions outside of the highly conserved ATPase/helicase domains
can profoundly influence ATPase and remodeling functions of
these enzymes. The nucleosome remodeling activity of CHD5 has
so far not been investigated and it remains to be formally
demonstrated that CHD5 is an active enzyme.
CHD3 and CHD4 exist in multiprotein complexes referred to
as Nucleosome Remodeling and Deacetylation (NuRD) complexes
[14,15]. In neural tissue, CHD5 associates with several NuRD
components suggesting that it exists in complexes similar to NuRD
[16,17].
Two CHD proteins have been implicated in cancer: CHD4 has
recently been found to be mutated in 17% of serous endometrial
tumours [18]. Interestingly, many missense mutations identified in
this tumour map to the catalytic domain of the enzyme suggesting
that loss of remodeling activity may contribute to malignant
transformation. CHD5 resides within a region commonly deleted
in neuroblastoma (1p36). Several studies have suggested that
CHD5 is a relevant tumour suppressor inactivated in neuroblas-
toma [7,19–23]. Indeed, in neuroblastoma loss of heterozygosity
often occurs by promoter methylation of the remaining CHD5
Figure 1. CHD5 is a nucleosome stimulated ATPase. (A) Schematic drawing of CHD3, CHD4 and CHD5 proteins showing conserved domains
and the CHD5 specific sequence. (B) Table showing sequence identity between different domains of CHD3, CHD4 and CHD5. (C) Expression of
recombinant CHD5. Recombinant CHD5-Flag was purified from extracts of baculovirus-infected Sf9 cells. Extracts were incubated with anti-Flag
affinity resin, washed and eluted with an excess of Flag peptide. Purified protein was seperated by SDS-PAGE followed by Western blotting with
CHD5 antibody (lane 1) or silver staining (lane 2). Asterisk indicates degradation products with intact anti-CHD5 epitope. (D) CHD5 is a nucleosome-
stimulated ATPase. Purified recombinant CHD5-Flag was subjected to ATPase assay as described in Materials and Methods. Different amounts of
recombinant human CHD5-Flag, naked DNA or in vitro assembled nucleosomes were used as indicated at the bottom of the panel. Reaction products
were separated by thin layer chromatography and the amount of released 32Pi was quantitated. The percentage of ATP hydrolysis was calculated for
each reaction. The percentage of ATP hydrolysis of control reactions (without enzyme) was set to one. Error bars depict the standard deviation of 3
independent experiments.
doi:10.1371/journal.pone.0098203.g001
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gene. Introduction of recombinant CHD5 into these cells inhibits
proliferation, clonogenicity and tumour formation in xenograft
assays.
In contrast to CHD3 and CHD4 which are expressed in many
cell types, CHD5 has a highly restricted expression pattern.
Initially, only neuronal tissues were reported to have robust CHD5
expression [17,24,25]. Very recently, CHD5 was shown to be also
expressed in mouse testis [26]. CHD5-deficient mice produce
sperm with aberrant morphology and insufficient chromatin
condensation [26]. The molecular mechanisms of CHD5 function
during spermatogenesis are not known. It is striking that loss of
CHD5 function in differentiating germ cells is not rescued by
CHD3 and CHD4 which are expressed at high levels in testis
tissue [26].
Spermatogenesis is a strictly regulated process that is initiated
immediately after birth and involves several mitotic divisions
followed by a long meiotic prophase (two weeks in mice and men).
Two meiotic divisions then generate haploid round spermatids.
Subsequently, spermiogenesis results in the compaction of the
sperm head and differentiation of acrosome and sperm tail.
During meiotic prophase, chromosomes pair and recombine in
order to ensure correct segregation of homologous chromosomes
during the first meiotic division. The X and Y chromosomes pair
only in short homologous pseudoautosomal regions and form a
transcriptionally inactive chromatin domain (XY body) [27].
During postmeiotic development, X and Y remain partially
silenced [28,29]. As spermatid nuclei start to elongate and
condense, histones are modified and subsequently replaced by
transition proteins and protamines, yielding a compact and
completely transcriptionally silenced genome [30,31]. Finally,
morphologically mature sperm are released into the fluid-filled
lumen of the seminiferous tubules. In CHD5 deficient mice
histone acetylation during spermiogenesis is impaired [26]. This
suggests a potential role of CHD5 in the histone-to-protamine
switch.
In this study we use recombinant CHD5 protein to demonstrate
for the first time that CHD5 possesses nucleosome-stimulated
ATPase activity in vitro. We find that CHD3/4 and CHD5 have
strikingly different expression patterns in mouse brain and testis:
CHD3/4 are widely expressed in neurons of different brain areas.
By contrast, CHD5 expression is restricted to distinct subpopu-
lations of neurons with defined topography in the cerebellum and
the hippocampus. In adult testis, CHD3/4 and CHD5 are
expressed in a mutually exclusive manner. CHD3/4 expression is
highest in somatic cells and germ cells at early stages of spermato
genesis. These cell types are devoid of CHD5 signal. Instead,
strong CHD5 expression is detected in cells that have progressed
to the later stages of spermatogenesis. Intriguingly, both CHD3/4
and CHD5 associate with pericentromeric regions of both
autosomes and sex chromosomes at particular stages of spermato-
genesis and colocalise with macroH2A1.2, a histone variant
implicated in organising heterochromatin. In addition, both
remodelers show highly specific interactions with specific regions
on the sex chromosomes. Our data demonstrate that the highly
related ATP-dependent nucleosome remodelers CHD3/4 and
CHD5 are differentially expressed during spermatogenesis. Their
reciprocal expression and association with chromosomes during
spermatogenesis indicates that CHD3/4 remodelers are replaced
by CHD5 to exert a specialised function in the context of
spermatid chromatin.
Results
CHD5 has nucleosome-stimulated ATPase activity
We sought to test if CHD5 has nucleosome remodeling activity
in vitro by assaying ATPase activity of recombinant CHD5. We
generated a baculovirus expressing Flag-tagged CHD5 and used
Flag affinity chromatography to purify recombinant protein from
extracts of infected cells (Fig. 1C). Proteins were bound to anti-Flag
affinity resin, extensively washed and eluted with an excess of Flag
peptide. Silver staining of the eluate revealed a prominent band
with an apparent molecular mass greater than 170 kDa (Fig. 1C,
lane 2). We confirmed the identity of this polypeptide as CHD5 by
Western blot analysis (Fig. 1C, lane 1).
We next subjected recombinant CHD5 to an in vitro ATPase
assay (Fig. 1D). Several CHD family members show robust
ATPase activity only in presence of DNA or nucleosomes.
Therefore, we included DNA or polynucleosomes in some
reactions. CHD5 displayed a dose-dependent basal ATPase
activity in the absence of DNA and nucleosomes. Addition of
DNA did not stimulate basal ATPase activity. By contrast,
addition of polynucleosomes increased CHD5 ATPase activity
two- to three-fold. These results suggest that CHD5 has
nucleosome-stimulated ATPase activity in vitro.
Expression of CHD5 isoforms in mouse brain and testis
In agreement with recently published data, we readily detected
CHD5 protein expression in extract derived from mouse brain
and testis whereas CHD5 was not detected in liver, lung or spleen
extracts (Fig. 2A) [9,17,18]. To extend this result we compared
Chd5 mRNA levels in mouse brain and testis. In the mouse, two
isoforms of Chd5 mRNA are predicted which differ in the inclusion
of exon 24. We considered that the expression of CHD5 protein in
mouse testis might be due to the tissue-specific expression of one of
these two isoforms. We made use of two sets of PCR primers to
distinguish between the two isoforms. RT-qPCR analysis demon-
strated that both mRNA isoforms exist and are expressed in both
tissues (Fig. 2B). We have detected no evidence for tissue-specific
expression of either isoform. Taken together, these results suggest
that two CHD5 isoforms are expressed in brain and testis.
CHD3/4 and CHD5 expression in brain
Brain and testis are composed of a multitude of different cell
types. In order to identify CHD5 positive cell types in both organs
and to compare the expression pattern of CHD5 with that of the
closely related CHD3 and CHD4 proteins we performed immuno
histochemistry using specific polyclonal antibodies on paraffin
sections of formalin-fixed mouse tissues. We used a CHD5
antibody that binds an epitope that is specific to CHD5. By
contrast, the CHD4 antibody recognises an epitope that is shared
between CHD3 and CHD4. Accordingly, cells and structures
stained with this antibody will be referred to as CHD3/4 positive.
In agreement with previous studies, CHD5 signal was detected in
the nuclei of neurons of the mouse hippocampus with a restricted
expression pattern predominantly in the neuron band of regions
CA1 to CA3 (Fig. 3, panels 1 and 2). CHD5 expression was not
detected in glial cells. In addition, we detected CHD5 in the nuclei
of a restricted subset of neurons in the cerebellar cortex localized
in the molecular layer (Fig. 3, panels 3 and 4). Also in other areas
of the mouse brain, CHD5 was found in subpopulations of
neurons (not shown). To directly compare the expression of
CHD3/4 and CHD5 in the cerebellar cortex we stained
consecutive sections with CHD3/4 (Fig. 3, panel 5) and CHD5
antibody (Fig. 3, panel 6), respectively. In contrast to CHD5,
CHD3/4 displayed a widespread expression in the nuclei of
CHD3/4 and CHD5 Expression during Spermatogenesis
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neuronal cells of the brain, including all regions and layers of the
hippocampus and the cerebellum (Fig. 3, panels 5 and 6, and data
not shown).
CHD3/4 and CHD5 expression in testis
We compared expression levels of CHD4 and CHD5 in testis
from 3 week old and adult mice by Western blot (Fig 4A). Whereas
CHD3/4 protein was readily detectable in both extracts, CHD5
expression was restricted to adult testis. This shows that CHD5
expression is upregulated during testis development and suggests
that CHD5 might be expressed in post-meiotic cells.
In order to define the cell types expressing CHD3/4 and CHD5
we analysed cross-sections of testis tubules by immunohistochem-
istry. In mice, spermatogenesis is intitiated in waves, and the cells
move from the basal compartment towards the lumen of the
seminiferous tubule during their development. The strict timing of
the different steps in spermato genesis, in combination with regular
entrance of a new group of differentiating spermato gonia into the
process, leads to an ordered association of cells. In mice, twelve
different cellular associations or stages (indicated by roman
numerals) have been defined [32]. This means that in a cross
section of a mouse testis, 12 different associations of spermatogenic
cells can be observed in the tubules. The different stages can be
identified by Periodic acid-Schiff (PAS) staining. Clearly, not all
cross sections of seminiferous tubules showed cells positive for
CHD5 (Fig. 4B, left panel). In addition, interstitial cells were all
negative for CHD5 (Fig. 4B, left panel). Zooming in on CHD5
positive tubules (Fig. 4B, middle and right panels) revealed that
Figure 2. CHD5 protein is expressed in brain and testis. (A) CHD5 protein is expressed in mouse brain and testis. Western blot was performed
with CHD5 antibody on lysates from different mouse tissues. Extracts from HEK cells transiently transfected with CHD5-Flag served as a positive
control. Lamin B was used as a loading control. (B) Two different CHD5 isoforms are expressed in mouse brain and testis. Panel 1: schematic
representation of the location of the PCR primers used to detect CHD5 cDNA of isoforms 1 and 2. Panel 2: schematic representation of part of the
CHD5 gene structure showing the two different putative splicing variants. Exons 23, 24 and 25 are indicated. Horizontal lines are introns. Diagonal
lines indicate splicing. Panel 3: RT-PCR detecting expression of different CHD5 isoforms in mouse testis and brain. H2O: negative control. Asterisk:
primer dimers.
doi:10.1371/journal.pone.0098203.g002
CHD3/4 and CHD5 Expression during Spermatogenesis
PLOS ONE | www.plosone.org 4 May 2014 | Volume 9 | Issue 5 | e98203
CHD5 expression was excluded from nuclei in the basal part of
the seminiferous tubules, indicating that the protein is not
expressed in Sertoli cells, spermatogonia, and spermatocytes. In
Stage III–VIII sections, CHD5 expression was detected in small
round nuclei, representing the postmeiotic round spermatids, that
locate in the upper third of the seminiferous tubule epithelium.
CHD5 expression was highest in the late round spermatids (stages
VII and VIII), and disappeared early during spermatid elongation.
To verify that CHD5 expression is restricted to postmeiotic
cells, we costained tubule crossections with CHD5 and cH2AX
antibodies. cH2AX is a variant of H2AX that is phosphorylated at
Ser139. This modification marks the chromatin surrounding DNA
double strand breaks, which are formed early during meiotic
prophase [33]. In addition, cH2AX is highly enriched on the
chromatin of the X and Y chromosome pair during pachytene
[33]. This area of the nucleus is transcriptionally silent and known
as the sex body, or XY body (for review see [34]). The results
clearly show that CHD5 is only expressed in cH2AX negative
postmeiotic cells (Fig. 4C).
Comparison of CHD3/4 and CHD5 in mouse testis revealed an
unexpectedly complementary expression pattern (Fig. 4D). Sertoli
cells, spermatogonia and spermatocytes, which showed no
detectable CHD5 expression, displayed the strongest CHD3/4
signals. CHD3/4 expression was very low or undetectable in
round spermatids and in later stages of spermatogenesis. Interest-
ingly, as described above, CHD5 showed the exact opposite
expression profile, with its expression starting in early round
spermatids. Both, CHD3/4 and CHD5 were not detectable in
condensed spermatids, nor in mature sperm released into the
lumen.
Chromosomal associations of CHD3/4 during meiotic
prophase
To study the intranuclear localization patterns of CHD3/4 and
CHD5 in spermatogenic cell types in more detail, we performed
immunocytochemistry on spread nuclei from adult mouse testes.
In spermatocytes, progression of meiotic prophase can be assessed
by making use of an antibody that recognizes a component
(SYCP3) of the protein complex (synaptonemal complex) that
physically connects the chromosome axes as they pair, thereby
achieving synapsis. When all chromosomes have completed
synapsis, the pachytene substage has been reached, and 19
autosomal synaptonemal complexes can be observed as thick lines
(Fig. 5). The X and Y chromosomal axes synapse only in the short
pseudoautosomal regions (PAR), and the rest of the chromosomal
arms remain unsynapsed and displays a thinner SYCP3 line. The
X and Y chromosome form the socalled XY body, which can also
be recognized as a somewhat more DAPI-dense region in the
nuclear spreads. Interestingly, while CHD5 is not detected in
spermatocytes (see above and data not shown), CHD3/4 shows a
dynamic pattern of localization during spermatocyte development.
At leptotene and zygotene, 150–250 meiotic DSBs are induced by
the transesterase SPO11. This enzyme generates approximately
200–250 DSBs and repair of these breaks is instrumental for
correct chromosome pairing [35,36]. In these early meiotic
prophase cells, CHD3/4 levels were low and dispersed over the
chromatin, with clear foci (4 to 8) on the ends of a few
chromosomal axes (Fig. 5). In early pachytene, CHD3/4 was
highly enriched along the short synapsed stretch of the XY pair,
corresponding to the pseudoautosomal region. Somewhat later
during pachytene, the rest of the XY body also showed
enrichment, in particular the (peri)centromeric region of the X.
In diplotene, CHD3/4 was no longer clearly enriched on the XY
body, but accumulated more on the DAPI-dense (peri)centromeric
chromatin of the autosomes (Fig. 5).
CHD3/4 is involved in regulating DNA double-strand break
(DSB) repair [37]. In addition, the protein accumulates at sites of
DNA damage [37–39]. The diffuse CHD3/4 staining pattern in
leptotene and zygotene, with only a few foci at chromosome ends
does not indicate that the protein is directly recruited to the .100
sites of meiotic DSB repair on the chromosomal axes [36,40].
Nevertheless, we wished to asses whether the accumulation of
CHD3/4 on chromatin in meiotic prophase cells could be a
response to the presence of meiotic DSBs. Meiotic DSB formation
is accompanied by nucleus wide formation of cH2AX [33]. As
DSB repair and chromosome pairing progress, cH2AX gradually
disappears from autosomes, but accumulates on the XY body [33].
In the absence of the enzyme (SPO11) that generates the meiotic
DSBs, chromosome pairing is severely disrupted and cH2AX
accumulates only in a small transcriptionally silenced subnuclear
region named pseudo XY body [41,42], most likely triggered by
the combination of the presence of a few spontaneous DSBs and
asynapsed chromatin [43]. This region only rarely encompasses
the X and Y chromosomes, but covers part of the asynapsed
chromatin [44,45]. In Spo11 null mutant mice (Spo11YF/YF),
spermatocytes arrest at a stage corresponding to early pachytene
in wild type, but with a zygotene-like appearance, similar to what
has been observed in Spo11 knockout mice [41–43]. We performed
triple stainings for cH2AX, SYCP3 and CHD3/4 in wild type and
Spo11 null mutant spermatocytes and observed that there was no
clear colocalisation between CHD3/4 foci and the global
accumulation of cH2AX in wild type leptotene and zygotene
nuclei (Fig. 6A, left panel). CHD3/4 only colocalises with cH2AX
in the XY body of early pachytene wild type spermatocytes
(Fig. 6A, left panel). In Spo11 null mutant leptotene and zygotene
Figure 3. CHD5 protein is expressed in a specific subset of
neurons in the brain whereas CHD3/4 is widely expressed.
Mouse brain sections were immunostained with antibodies against
CHD5 or CHD3/4 and antibody binding was detected using a
peroxidase labeled secondary antibody and 3,3’-diaminobenzidine
(DAB) as a substrate. (1) CHD5 positive neurons in the hippocampus
(206 magnification). (2) 2006 magnification of CHD5 positive
hippocampal neurons. (3) CHD5 positive neurons in the cortex of the
cerebellum (1006 magnification). (4) 4006 magnification of CHD5
positive cerebellar neurons. (5) and (6) consecutive sections of
cerebellum showing CHD3/4 (5) and CHD5 (6) expression.
doi:10.1371/journal.pone.0098203.g003
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nuclei, we still observed CHD3/4 foci at the ends of some of the
axes (Fig. 6A, right panel), and in the majority of the later stage
nuclei we also observed CHD3/4 enrichment on the chromatin
area that encompassed the pseudo XY body, as evidenced by
enrichment for cH2AX (Fig. 6A, right panel). Since the pseudo
XY body only rarely includes the X or Y chromosome, we
determined whether any of the foci observed on ends of axial
elements actually represented the pseudoautosomal regions, by
combining SYCP3 and CHD3/4 immunostaining with a FISH for
the PAR region. Figure 6B shows a representative result in which
it is clear that CHD3/4 is enriched at the PAR in zygotene Spo11
null spermatocytes, and at some other chromosome ends that react
weakly with the PAR probe for unknown reasons. Also in wild type
nuclei, at a very late zygotene stage, the PAR of both the X and
the Y chromosome accumulates CHD3/4, before the two
chromosomes synapse (Fig. 6A, left panel).
Chromosomal associations of CHD5 during spermatid
differentiation
In round spermatids, CHD3/4 expression was absent (see above
and data not shown), and CHD5 signal could be detected in some
of the spermatid nuclei. CHD5 was enriched in the round DAPI-
dense area named chromocenter, that contains the (peri)centro-
meric chromatin (Fig. 7A, B). In some of the round spermatids we
observed a spot within or at the edge of the chromocenter that was
most intensely stained (Fig. 7A, B). The spot is also adjacent to the
area that encompasses the sex chromosome, which can be
recognized by a distinct DAPI intensity, that is somewhat more
Figure 4. Expression of CHD3/4 and CHD5 is reciprocally regulated during spermatogenesis. (A) Western blot analysis CHD3/4, CHD5
and lamin expression in lysates from 3 week-old and from adult mice. Extracts from HEK cells expressing recombinant CHD5-Flag and extracts from
murine brain were used as positive controls for CHD5 expression. Antibodies used for Western blot are indicated. (B) CHD5 protein is maximally
expressed in round spermatids at Stages VII–VIII of the spermatognenic cycle. Upper images show results of the immunostaining and the bottom
images show the PAS staining pattern of a section directly adjacent to the section shown above it. Left panel: low magnification (scale bars indicate
0.5 mm) of a mouse testis containing seminiferous tubules in different spermatogenic stages. Middle and right: higher magnification of the areas
(scale bars indicate 0.05 mm) marked in the left panel, roman numerals indicate the stages of the spermatogenic cycle. (C) CHD5 is expressed in
postmeiotic cells. Immunofluorescence analysis was performed using CHD5 antibody and visualized with confocal microscopy. Panel 1: Nuclei stained
with DAPI. Panel 2: CHD5 staining, the outline of the tubule as seen in panel 1 is indicated with white lines. Panel 3: phosphorylated H2AX (cH2AX)
staining. Spermatocytes in late meiotic prophase (pachytene and diplotene), show intense staining in a subregion of the nucleus (XY body) (arrow).
Earlier spermatocytes (at the more basal part of the tubule) show nucleus wide cH2AX staining (arrowhead). Panel 4: overlay of the DAPI, CHD5 and
cH2AX channels. (D) CHD5 and CHD3/4 expression at different stages of spermatogenesis. Panel 1: CHD5 is expressed in post-meiotic cells (1006
magnification). Panel 2: CHD3/4 is expressed in the area where spermatogonia, Sertoli cells and spermatocytes are present (1006magnification).
Panel 3: CHD5 immunostaining (2506magnification). Panel 4: CHD3/4 immunostaining (250x). Formalin-fixed paraffin-embedded tissue sections
were immunostained with the antibodies indicated.
doi:10.1371/journal.pone.0098203.g004
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Figure 5. Localization patterns of CHD3/4 in spread nuclei of spermatocytes. Spread wild type mouse spermatocyte nuclei immunostained
for CHD3/4 (green), SYCP3 (red), and counterstained with DAPI (blue). In wild type spermatocytes, CHD3/4 is most enriched on some ends of axial
elements in zygotene (white arrows), then mainly on the pseudoautosomal region (PAR, P) in early (e) pachytene (see also enlargements at the
bottom). Subsequently, all XY chromatin is somewhat enriched in mid (m) pachytene, followed by more specific restriction to the par and the X
centromere in late (l) pachytene (enlargement on the bottom of the middle panel). In early and late diplotene, CHD4 enrichment is observed on
centromeric heterochromatin, and more evenly distributed on the XY body (enlargement on the bottom of the right panel). XY bodies are indicated
CHD3/4 and CHD5 Expression during Spermatogenesis
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intense than the noncentromeric chromatin, and less intense than
the chromocenter. The sex chromosome in spermatids is known to
carry enrichments for some specific histone modifications, such as
for example H3K9me2, which can be observed in a subfraction of
the spermatids as indicated in Figure 7C. In spermatids, cH2AX
foci mark DNA breaks that are transiently present in elongating
spermatids. At this stage, CHD5 expression is no longer detectable
(not shown), indicating that also CHD5 accumulation in round
spermatids is not induced by the presence of DNA damage.
The enrichment of CHD3/4 in the XY body and on
centromeric heterochromatin in spermatocytes, and the localiza-
tion of CHD5 on the chromocenter and an extra spot in round
spermatids is very reminiscent of the staining pattern that has been
described for macroH2A1.2 [46]. This study has shown that the
focus of macroH2A1.2 enrichment in round spermatids colocalises
with the (peri)centromeric region of the Y chromosome. Based on
this information, we compared the expression of macroH2A1.2 to
that of CHD3/4 and CHD5 in spermatocytes and spermatids,
respectively. In wild type pachytene nuclei, we indeed observed
that CHD3/4 is enriched in areas that are also enriched for
macroH2A1.2 (Fig. 8A). However, in diplotene, when most
CHD3/4 was lost from the XY body, macroH2A.1 was still
enriched on the PAR and the centromeric regions. In Spo11 null
spermatocytes, we observed colocalisation of macroH2A.1 and
CHD3/4 in the pseudoXY body, whereby macroH2A.1 was
usually more clearly enriched than CHD3/4 (Fig. 8B).
In accordance with previous observations [46], we observed
macroH2A.1 in a focal spot at the border of the chromocenter in
approximately half of the round spermatids that were scored (115/
217). Colocalisation with CHD5 was observed in 54 of the 115
spermatids that were macroH2A.1-positive (Fig. 8C). It has been
shown that the macroH2A.1 spot in the chromocenter is observed
specifically in spermatids that contain the Y chromosome [46],
and it was suggested that the spot corresponds to the Y
centromere. To verify whether both CHD5 and macroH2A.1
colocalise on the Y centromere, we co-stained round spermatids
for the centromere marker CREST and either CHD5 or
macroH2A.1. For both proteins we observed no specific
colocalisation with CREST (Fig. 8D), indicating that the proteins
are enriched on a noncentromeric region of the Y chromosome.
Since CHD5 is not enriched on all round spermatids, we
wondered if the level of CHD5 could be related to the overall level
of gene transcription. We used an antibody against RNA
polymerase II as a marker for overall transcriptional activity in
combination with CHD5, but observed CHD5 accumulation in
the chromocenter and the Y-chromosome specific spot both in
nuclei with high and with low levels of RNA polymerase II (Fig. 8E)
Discussion
CHD5 is a nucleosome stimulated ATPase
CHD3 and CHD4 can remodel nucleosomes in an ATP-
dependent manner in vitro. Recently, regions flanking the ATPase
domain of CHD proteins have been demonstrated to interact with
the ATPase domain and to regulate enzyme activity by
modulating the interaction of the enzyme with DNA and
nucleosome substrates [11–13]. The ATPase domains of CHD3,
CHD4 and CHD5 are highly conserved. However, amino acid
sequence conservation in the flanking regions is not as high. In
particular, CHD5 contains a unique 181 amino acid stretch in the
C-terminus suggesting possible differences in intramolecular
interactions and ATPase regulation. Here, we have shown that
recombinant CHD5 hydrolyses ATP in vitro, thus demonstrating
for the first time that CHD5 is indeed an active ATPase enzyme.
Previous work has shown that recombinant CHD4 ATPase is
stimulated to a similar extent by both free DNA and nucleosomes,
a property that is shared by ATP-dependent nucleosome
remodelers of the SWI/SNF family [47]. In contrast, we find that
CHD5 ATPase activity is stimulated by nucleosomes but not
significantly by free DNA. This suggests differences between
CHD4 and CHD5 in the way ATPase activity is regulated in the
presence of different DNA substrates. Since addition of nucleo-
somes significantly activates the CHD5 ATPase, it is likely that
CHD5 remodels nucleosomes in vitro.
Why do vertebrates express three remodeling enzymes (CHD3,
CHD4 and CHD5) that are highly related in their amino acid
sequences? Moreover, all three enzymes reside in multisubunit
protein complexes with similar subunit composition [16,17]. One
possibility is that these enzymes perform related but different
chromatin remodeling reactions. The differences in ATPase
activities described above are consistent with such a hypothesis.
Related enzymes often show distinct expression patterns and
provide tissue-specific functions. Indeed, the expression patterns of
CHD3/4 and CHD5 are markedly different. Initially, CHD5 was
found to be exclusively expressed in tissues of neural origin
[17,24,25]. This data is supported by comparative analysis of
CHD3, CHD4 and CHD5 mRNA expression (Figure S1).
Whereas CHD3 and CHD4 are expressed at high levels in 17
mouse tissues examined, CHD5 showed significant expression in
brain only. This analysis did not detect significant CHD5 mRNA
expression in testis. In contrast, our semi-quantitative measure-
ment of CHD5 mRNA in testis extract suggests that CHD5
expression in testis is even stronger than in brain. The reasons for
this discrepancy are currently unclear. However, Zhuang and
colleagues [26] have recently used quantitative RT-qPCR to
compare CHD5 expression levels in brain and testis. They have
found that CHD5 mRNA is four times more abundant in testis
extract. This finding agrees well with our results. In addition, the
analysis of CHD5 protein expression in testis by Western blot,
immunohistochemistry and immunofluorescence confirms robust
CHD5 expression in this tissue (our study and [26]).
In this study, we have also demonstrated the existence of two
alternatively spliced CHD5 mRNA isoforms that had been
predicted by sequence analysis. Both isoforms are expressed in
brain and testis. They differ by the inclusion/exclusion of exon 24.
The predicted difference in the molecular masses of the resulting
proteins is too small to be separated by SDS-PAGE and Western
blot analyses. Therefore, it is currently unknown to what extent
both isoforms are expressed at the protein level.
In the brain, CHD5 is expressed as a nuclear protein in distinct
subsets of neurons, with particularly clear topographical patterns
in the hippocampus and cerebellum. We did not detect CHD5 in
non-neuronal cell types. Our data agree well with previous
analyses of CHD5 expression in human brain [17,24]. We also
compared for the first time the expression patterns of CHD4 and
CHD5 in the mouse brain. It is evident that CHD3/4 expression
is broader than CHD5, encompassing most neuronal cells. In the
molecular layer of the cerebellum most neurons show immuno-
staining for both CHD3/4 and CHD5 as evident from consecutive
sections. These data suggest that at least some neural populations
coexpress both CHD3/4 and CHD5. Preliminary analyses of
human cerebellum suggest expression patterns of CHD3/4 and
with dashed rectangles in the images. In the enlargements, X and Y indicate the axes corresponding to the X and Y chromosome, respectively.
doi:10.1371/journal.pone.0098203.g005
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Figure 6. CHD3/4 localisation in spermatocytes is independent of SPO11. (A) Spread wild type (left) and Spo11 null (Spo11YF/YF, right)
spermatocytes stained for CHD3/4 (green), SYCP3 (red), and cH2AX (blue), the single CHD3/4 staining is shown in white to the right of each merge. In
wild type nuclei, CHD3/4 does not colocalise with cH2AX in leptotene and zygotene. Specific foci accumulate on some chromosome ends (asterisks
indicate examples), in particular on the pseudoautosomal region (PAR) of both X and Y, as can be observed in the late zygotene nucleus (white
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CHD5 similar to those observed in mouse cerebellum (data not
shown).
Our analysis of CHD3/4 and CHD5 expression in mouse testis
has revealed that expression of both remodelers is developmentally
regulated during spermatogenesis. CHD3/4 is expressed in both
germ cells and Sertoli cells, whereas CHD5 was detected in germ
cells only, indicating a germ cell specific function of CHD5.
Indeed, we found that the patterns of CHD3/4 and CHD5
expression during spermatogenesis are mutually exclusive;
CHD3/4 is present in spermatogonia and spermatocytes, but
not in the postmeiotic spermatids, whereas CHD5 expression
initiates during round spermatid development, with a peak in step
VIII spermatids, followed by a dramatic reduction to undetectable
levels in step IX spermatids. The opposing expression profiles of
CHD3/4 and CHD5 during spermatogenesis suggest that CHD5
replaces CHD3/4 to carry out a specialised function. The
differences in the biochemical properties of CHD3/4 and
CHD5 described above are consistent with this hypothesis.
Spermatogenesis is characterised by a series of dramatic
chromatin remodeling events. In meiotic prophase, DNA
double-strand breaks are specifically induced at sites that carry a
specific histone modification signature, and the H3.1 containing
nucleosomes of the transcriptionally silenced XY pair in the XY
body are completely replaced by H3.3 containing nucleosomes
[48]. This process is also accompanied by dynamic changes in
histone modifications. In addition, meiosis-specific histone variants
are incorporated in a global manner at different stages of germ cell
development and finally, during postmeiotic spermatid elongation,
the vast majority of histones are replaced by transition proteins
and subsequently by protamine. These chromatin remodeling
processes are unique to spermatogenesis and are likely to require
specialised chromatin remodeling machines.
Our expression study suggests that CHD3/4 performs a specific
function in the pseudoautosomal region during early meiotic
prophase. This region is of special interest in the context of meiotic
DSB repair since it contains a super hotspot for SPO11 activity,
that ensures that a crossover is formed in this small region in all
spermatocytes [49]. We observe CHD3/4 foci at the X and Y
PAR well before the two chromosomes have associated, in
leptotene spermatocytes, independent of SPO11 activity. It might
therefore be suggested that CHD3 or CHD4 is involved in the
generation of an open chromatin structure at the PAR hotspot,
arrows). The inserted image shows part of the same nucleus with the X and Y chromosomal axes in white, for easy recognition. In pachytene, cH2AX
and CHD3/4 colocalize on the XY body whereby CHD4 is particularly enriched on the PAR (white arrow) and the X centromere (asterisk). In Spo11 null
spermatocytes enrichment of CHD3/4 is observed on some chromosome ends in early zygotene (asterisks indicate examples), and in the pseudo XY
body (white arrow) of later zygotene-like spermatocytes. (B) Spread Spo11 null zygotene spermatocyte stained for SYCP3 and CHD3/4, and hybridized
with a BAC probe recognizing the PAR. In the merge, an enlargement of the region encompassing the X and Y is shown (scale bar indicates 5 mm). In
this nucleus CHD3/4 stain the PAR of the X and Y, but also mark the ends of 4 additional chromosome ends, that are also recognized, to a lesser
extent, by the PAR probe. It is not clear what causes this crossreaction (see Materials and Methods).
doi:10.1371/journal.pone.0098203.g006
Figure 7. CHD5 is enriched in pericentromeric chromatin of round spermatids. (A, B) Spread nuclei of spermatids immunostained for CHD5
and counterstained with DAPI. An example of a round spermatid nucleus that is positive for CHD5 expression and displays the high intensity focus in
the chromocenter is shown in A and such an example is also indicated with a white arrow in B, the yellow arrow indicates a spermatid nucleus that
expresses CHD5, but does not have the extra CHD5 focus. The green arrow indicates a CHD5-negative round spermatid nucleus. (C) Spread nuclei of
spermatids immunostained for CHD5 and H3K9me2, and counterstained with DAPI. The nuclear area encompassing the chromatin of the sex
chromosome is indicated with a dashed line H3K9me2 marks the chromocenter and the sex chromosome in the left (early) round spermatid nucleus,
and mainly the sex chromosome in the right (late) round spermatid nucleus. CHD5 level is very low in the left nucleus, but clearly enriched in the
chromocenter and the focus (indicated with a white arrow) adjacent to the chromocenter and Y chromosome chromatin in the right nucleus.
doi:10.1371/journal.pone.0098203.g007
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preparing it for very efficient cutting by the isoform of SPO11 that
is specifically involved in this function [50]. It is surprising that
CHD3/4 does not form foci at the meiotic DSBs, since CHD4 is
recruited to laser-induced DSBs in cultured mammalian somatic
cells [37–39]. Since the recruitment of CHD4 to DSBs in somatic
cells is thought to depend on PARylation and result in recruitment
of RNF168 and resultant H2A ubiquitylation, it is of interest to
note that global H2A ubiquitylaton does not occur in association
with meiotic DSB formation [51]. Instead, this modification, and
also the PARylating enzyme PARP-2 accumulate at the XY body.
Moreover, in Parp-2 knockout mice, XY body formation appears
to be affected and overall crossover formation was reduced [52].
Finally, PARP protein has been reported to bind to a hotspot
consensus site [53]. Taken together, our data support the
hypothesis that the CHD3/CHD4 staining pattern in zygotene
and early pachytene spermatocytes is related to a CHD4
remodeling function in association with the PAR hotspot, and
not a function that is directly related to a response to DSBs. The
localisation to (peri)centromeric heterochromatin during later
meiotic prophase may reflect a function of CHD4 in regulation of
transcriptional repression at these sites [54].
The timing of CHD5 expression during spermatogenesis
described in this study and the defects of CHD5-deficient sperm
described by the Brodeur lab raise questions about the role of
CHD5 in the histone-protamine switch and chromatin condensa-
tion [26]. At present, our knowledge of the mechanisms
contributing to the histone-protamine exchange is limited and
the factors involved are only beginning to be characterised. A
major role is played by a global wave of histone hyperacetylation
(in the absence of active gene transcription), which may lead to a
more open chromatin structure that subsequently may facilitate
replacement by transition proteins and protamines. Recently, the
testis-specific bromodomain protein BRDT which binds acetylated
nucleosomes was demonstrated to regulate histone removal and
incorporation of transition proteins [55]. In addition, testis-specific
H2B variants such as TH2B have been shown to play important
roles in the histone-protamine switch [56]. Accordingly, it has
been suggested that the whole process may occur without direct
involvement of ATP-dependent chromatin remodelers (reviewed
by [31]). The preferred localization of CHD5 to (peri)centromeric
heterochromatin may also indicate that it is not directly involved
in histone removal, but perhaps in ensuring that the centromeric
nucleosomes are retained, since these are known to be transferred
to the zygote [57]. Moreover, CHD5 expression appears to peak
when global gene transcription shuts down, prior to histone
removal [58]. Thus, it might also be suggested that CHD5 is
involved in mediating this global transcriptional repression, in
particular since CHD5 follows the localization pattern of
macroH2A.1, which is also known to be involved in transcriptional
repression. Alternatively, CHD5 might actively contribute to
global histone acetylation as H4 hyperacetylation levels are
decreased in CHD5-deficient spermatids [26]. Future functional
analyses of CHD3/4 and CHD5 and identification of their specific
binding partners in spermatocytes and spermatids, respectively,
will help to further delineate the specific functions of these
chromatin remodelers in spermatogenesis.
Materials and Methods
Generation of CHD5-Flag constructs
A CHD5 cDNA construct was kindly provided by G.M. Brodeur
[20]. This cDNA clone was used as a template for PCR to
generate hChd5-Flag/pcDNA3.1/V5-His-TOPO and Chd5-
Flag/pVL1392 constructs. hChd5-Flag/pcDNA 3.1/V5-His-
TOPO was used to produce CHD5 expressing cell extract
whereas Chd5-Flag/pVL1392 was used to generate recombinant
human CHD5-Flag.
ATPase assay
Human recombinant CHD5-Flag was produced using the
baculovirus system as decribed in [59]. The recombinant protein
was purified by Flag-immunoprecipitation and eluted with Flag
peptide (Sigma-Aldrich F3290) according to the manufacturer’s
instructions. The eluted material was loaded on SDS-PAGE
followed by silver staining or anti-CHD5 (Santa Cruz sc-68390
(H-185)) Western blotting. The recombinant protein was then used
in the ATPase assay as described in [60].
Mouse tissue and cell line nuclear extracts
Nuclear extracts were prepared from mouse tissues using a
protocol adapted from [61]. Tissues were homogenized in lysis
buffer (50 mM tris, 5 mM EDTA, 150 mM NaCl) and centri-
fuged. Pellets were homogenized in homogenization buffer
(10 mM Hepes pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.1 mM
EDTA and 0.1 mM EGTA) and incubated for 15 minutes on ice.
NP-40 was added to a final concentration of 3% and extracts were
vortexed, incubated for 30 minutes on ice and shortly spun down.
Finally, nuclear pellets were resuspended in ice-cold nuclear
extract buffer (20 mM Hepes pH 7.9, 420 mM NaCl, 1.5 mM
MgCl2, 1 mM EDTA and 1 mM EGTA). As a positive control for
CHD5 expression, extract from CHD5-Flag overexpressing cells
was used. Cell line extract was prepared using a standard protocol
for cell lysis. For overexpression, the Hek293 cell line which is
derived from human embryonic kidney cells was transiently
transfected with CHD5-Flag/pcDNA3.1/V5-His-TOPO. West-
ern blotting of extracts was performed according to standard
procedures using the primary antibodies anti mouse-CHD5 rabbit
polyclonal (Santa Cruz Biotechnology (M-182) sc-68389) and anti
Lamin B goat polyclonal (Santa Cruz Biotechnology (M-20) sc-
6217).
Mouse tissue mRNA extraction and RT-PCR
RNA from mouse tissue was extracted using Trizol (Invitrogen)
according to the manufacturer’s protocol. 2 mg of RNA (with an
optical density between 1.8 and 2.2) was reverse transcribed into
cDNA by incubation with 0.5 mg oligo(dT) primers (MWG) and
200 U M-MLV reverse transcriptase (Invitrogen) according to the
manufacturer’s protocol. Quantitative (Q)PCR was performed
Figure 8. macroH2A colocalizes with CHD3/4 in spermatocytes and with CHD5 in spermatids. (A,B) Spread wild type (A) and Spo11 null
(Spo11YF/YF) (B) spermatocyte nuclei stained for MacroH2A.1 and CHD3/4. Colocalisation on the PAR and the X centromere is observed in pachytene,
but not in diplotene nuclei of wild type spermatocytes. In the absence of functional SPO11, some zygotene-like nuclei show enrichment of both
CHD4 and macroH2A.1 in the pseudo XY body. (C) Spread spermatid nucleus stained for CHD5, and MacroH2A, colocalisation of the CHD5/MacroH2A
focus in the chromocenter is clear in the merge with DAPI (right image). (D) Spread spermatid nuclei stained with macroH2A (green) and CREST (red,
left panel) or with CHD5 and CREST (right panel). The enlargements in the middle of each panel clearly show that the macroH2A.1/CHD5 spot in the
chromocenter does not colocalise with CREST marking of the centromeres. (E) Spread spermatid nuclei costained for CHD5 and RNA polymerase II.
Both high and low levels of RNA polymerase II can be observed in nuclei that express CHD5.
doi:10.1371/journal.pone.0098203.g008
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using Absolute QPCR SYBR Green Mix (Thermo Scientific) and
analyzed by the Stratagene Mx3000P real-time detection system
(Agilent). At least two independent experiments were performed
and all amplifications were done in triplicate. Relative gene
expression was determined by calculating 2-DDCt values. Values
were obtained by normalization using the housekeeping gene
RPS14 and a non-CHD5 expressing calibration sample. For semi-
quantitative RT-PCR, standard PCR reactions using CHD5
isoform-specific primers were performed on cDNA. The PCR
primers used for detection of CHD5 and housekeeping genes in
mouse tissue are:
b-actin forward: 5’-gatctggcaccacaccttct-3’; b-actin reverse: 5’-
ggggtgttgaaggtctcaaa-3; CHD5 isoform 1 forward: 59-cgtggaagg-
catgatgt-39; CHD5 isoform 1 reverse: 59-ctttgttatcgcctggc-39;
CHD5 isoform 2 forward: 59-gtggaaggcgataacaaag-39; CHD5
isoform 2 reverse: 59-aggtactcgttcatgttct-39.
Immunohistochemistry and immunocytochemistry
Stainings of formalin-fixed and paraffin-embedded mouse tissue
sections from testis and brain were performed using standard
immunohistochemistry protocols. Endogenous peroxidase activity
was blocked in 3% H2O2 (Merck) in methanol. For staining of
mouse testis, 8–10 mm thick deparaffinized sections were boiled in
citrate buffer (Dako target retrieval solution citrate pH 6).
Unspecific binding of primary and secondary antibody was
prevented by blocking with 10% normal goat serum (Dako
X0907) and 5% bovine serum albumin (BSA, Sigma A7034) in
phosphate buffered saline (PBS). As first antibodies polyclonal
rabbit anti mouse-CHD5 (Santa Cruz Biotechnology (M-182) sc-
68389) or anti Mi2 (Santa Cruz Biotechnology (H-242) sc-11378)
were used. As negative controls, slides were incubated in blocking
buffer (3% BSA/PBS-0.1%Tween) without primary antibody. As
secondary antibody a biotinylated goat anti-rabbit IgG (Dako,
E0432) was used. An amplification step was performed using the
ABC kit (Vectastain, Elite PK-6100 standard) together with the
chromogen substrate 3,3’-diaminobenzidine (Dako liquid DAB
substrate chromogen system K3468) for immunohistochemistry.
Sections were counterstained with hematoxylin and mounted with
mounting medium. To determine the stage of the cycle of the
seminiferous epithelium, adjacent sections were stained with
Periodic acid Schiff and analysed according to [32].
For immunohistochemistry on mouse brain, the following
modifications were employed: heat-induced antigen retrieval was
performed by treating the sections with Trilogy Pretreatment
Solution (Cell Marque) for 30 min in a household steamer. For
detection of CHD5, polyclonal rabbit anti human-CHD5 (Santa
Cruz Biotechnology (H-185) sc-68390) which is also reactive with
mouse CHD5 was used. The antibody incubation and washing
steps, including prior blocking of endogenous peroxidase activity,
were performed using an automated immunohistochemistry
apparatus (Autostainer plus; Dako). Detection of bound primary
antibodies was via Dako REAL Detection System Peroxidase/
DAB+, Rabbit/Mouse (Dako).
For immunofluorescent stainings of mouse testes cryosections,
no endogenous peroxidase inhibition step was performed. Primary
antibodies were anti mouse-CHD5 rabbit polyclonal (Santa Cruz
Biotechnology (M-182) sc-68389) and anti-gH2AX mouse mono-
clonal (Upstate #05-636, clone JBW301). Slides were incubated
with a fluorescent second antibody (Alexa Fluor 546 Goat Anti-
Rabbit or 488 Goat Anti-Mouse IgG (H+L), Life Technologies).
Sections were embedded with Prolong Gold antifade reagent
containing DAPI (Life Technologies P-36931).
Spread nuclei of spermatocytes from wild type and Spo11YF/YF
mutant mice were prepared as described (Peters et al., 1997) and
stored at 280C. Thawed slides were washed in PBS (3610 min),
and non-specific sites were blocked with 0.5% w/v BSA and 0.5%
w/v milk powder in PBS. Primary antibodies were diluted in 10%
w/v BSA in PBS, and incubations were done overnight at room
temperature in a humid chamber. Subsequently, slides were
washed (3610 min) in PBS, blocked in 10% v/v normal goat
serum (Sigma) in blocking buffer (supernatant of 5% w/v milk
powder in PBS centrifuged at 14,000 rpm for 10 min), and
incubated with secondary antibodies in 10% normal goat serum in
blocking buffer at room temperature for 2 hours. Finally, slides
were washed (3610 min) in PBS (in the dark) and embedded in
Prolong Gold with or without DAPI (Invitrogen). First antibodies:
rabbit polyclonal anti-SYCP3 (gift from C. Heyting), rabbit
polyclonal anti-CHD3/4 and antiCHD5 as described above,
rabbit polyclonal anti-macroH2A.1 (Upstate), mouse monoclonal
anti-H3K9me2 (Abcam), mouse monoclonal anti-gH2AX (Up-
state), RNA polymerase II (Abcam), and human autoantibodies
against the centromere (CREST, Cortex Biochem). For secondary
antibodies, we used a goat anti-rabbit alexa 488/546 IgG, goat
anti-mouse 488 alexa IgG and goat anti-human alexa 555 IgG,
respectively. When double-immunostainings were performed with
two rabbit polyclonal antibodies, these were performed in
consecutive order as follows: CHD3/4 or macroH2A.1+ SYCP3;
first SYCP3 (first and second antibody), then CHD3/4 or
macroH2A.1, respectively, CHD3/4 or CHD5 + macroH2A.1;
first CHD3/4 or CHD5 (first and second antibody) followed by
macroH2A.1 Fluorescent images were observed by using a
fluorescence microscope (Axioplan 2; Carl Zeiss) equipped with
a digital camera (Coolsnap-Pro; Photometrics).
Fluorescent in situ hybridization
A previously described BAC probe was used to detect the PAR
(Kauppi et al., 2011). The BAC (2.2 mg) was labelled with Biotin
(Biotin-Nick Translation Kit, Roche). After alcohol precipitation
in the presence of mouse Cot-1 DNA, the labeled DNA was
resuspended in 25 ml formamide. Slides were first immunostained
for CHD3/4 and SYCP3 as described above, and immunofluo-
rescent images were captured at positions that were recorded.
Then, the immunosignal was stripped from the slide as described
(van de Werken et al 2013). 2.5 ml probe was used in a total
volume of 20 ml hybridization mix. Denaturation was performed
at 80uC, followed by hybridization overnight at 37uC, washings
were performed in preheated formamid/1xSSC (1:1 (V/V)) for
265 minutes with shaking, followed by 3 washes of 5 minutes in
preheated 2xSSC, and one wash in 4xSSC/0.1% Tween-20 at
room temperature. Detection of the biotin-labelled probe was
performed with a primary antibody mouse anti-biotin (Roche
diagnostics) and a secondary donkey anti-mouse Rhodamin
(Jackson ImmunoResearch). Slides were mounted in Prolong gold
with DAPI (Life Technologies), and images were captured at the
recorded positions. The PAR probe reacts most strongly with the
PAR of the Y chromosome and somewhat more weakly with that
of the X. In addition, the PAR probe hybridizes to a few other
chromosome ends that are also positive for CHD3/4. These
additional foci are also observed when the CHD3/4 immuno is
not performed, and therefore do not reflect a crossreaction of
antibodies from the immune-staining with those used for detection
of the FISH signal.
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ungspraesidium Giessen). Project reference number: V54-19c20/
15cMR20/10 Nr. A 18/2010.
Supporting Information
Figure S1 Expression of CHD3, CHD4 and CHD5 mRNA in
17 mouse tissues. Expression data was retrieved from www.ncbi.
nlm.nih.gov/geoprofiles/(dataset GD3052; expression values dis-
played on Y-axis are displayed as arbitrary units)). This dataset
represents the analysis of 17 normal tissues from mouse and was
obtained using the Affymetrix Mouse Genome 430 2.0 Array.
(TIF)
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